menu
    • menu

    Company profile for Synthon Pharmaceuticals

    NEW Drugs in Dev: 2
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Synthon is a company committed to delivering affordable medicines through innovative science.Finding affordable solutions to today's health care challenges demands cutting-edge science, highly talented and motivated people and above all the ability to innovate. Innovation and continuous improvement are the heartbeat of our company. Our mission is to make health care more affordable, increasing access to important medicines...
    Synthon is a company committed to delivering affordable medicines through innovative science.Finding affordable solutions to today's health care challenges demands cutting-edge science, highly talented and motivated people and above all the ability to innovate. Innovation and continuous improvement are the heartbeat of our company. Our mission is to make health care more affordable, increasing access to important medicines through the provision of high quality small molecule generics, biosimilars and new biological and new chemical entities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Synthon PharmaceuticalsNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    PO Box 70716503 GN NijmegenThe Netherlands
    Telephone
    Telephone
    (+31) 24 372 77 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.synthon.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zydus, Synthon Ink Exclusive Licensing Deal for Ozanimod Capsules
    Zydus, Synthon Ink Exclusive Licensing Deal for Ozanimod Capsules

    04 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zydus-and-synthon-entered-into-exclusive-licensing-and-supply-agreement-for-ozanimod-capsules-generic-version-of-zeposia-for-the-us-market-302546536.html

    PR NEWSWIRE
    04 Sep 2025
    Share Share
    Synthon's Generics Ozanimod Receives Tentative Approval in US
    Synthon's Generics Ozanimod Receives Tentative Approval in US

    22 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219236

    FDA
    22 Jul 2025
    Share Share
    Zydus signs agreement with Synthon for 505(B)(2) oncology product
    Zydus signs agreement with Synthon for 505(B)(2) oncology product

    13 Feb 2025

    // EXPRESS PHARMA

    https://www.expresspharma.in/zydus-lifesciences-signs-agreement-with-synthon-bv-for-505b2-oncology-product/

    EXPRESS PHARMA
    13 Feb 2025
    Share Share
    Synthon Pharma`s Generics Glatiramer Acetate Receives Approval in US
    Synthon Pharma`s Generics Glatiramer Acetate Receives Approval in US

    25 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206873

    FDA
    25 Sep 2024
    Share Share
    Synthon`s Generics Glatiramer Acetate Receives Approval in US
    Synthon`s Generics Glatiramer Acetate Receives Approval in US

    25 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203857

    FDA
    25 Sep 2024
    Share Share
    Synthon Pharms Generic Palbociclib Receives Approval in US
    Synthon Pharms Generic Palbociclib Receives Approval in US

    05 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215570

    FDA
    05 Jun 2024
    Share Share

    USDMF

    read-more
    read-more

    01

    Axitinib

    Netherlands
    DCAT Week
    Not Confirmed
    arrow

    02

    Enzalutamide

    Netherlands
    DCAT Week
    Not Confirmed
    arrow

    03

    Ixazomib Citrate

    Netherlands
    DCAT Week
    Not Confirmed
    arrow

    04

    Lenalidomide

    Netherlands
    DCAT Week
    Not Confirmed
    arrow

    05

    Mirabegron

    Netherlands
    DCAT Week
    Not Confirmed
    arrow

    06

    Ozanimod Hydrochloride

    Netherlands
    DCAT Week
    Not Confirmed
    arrow

    07

    Palbociclib

    Netherlands
    DCAT Week
    Not Confirmed
    arrow

    08

    Pomalidomide

    Netherlands
    DCAT Week
    Not Confirmed
    arrow

    09

    Siponimod Adipic Acid

    Netherlands
    Pharma Europe
    Not Confirmed
    arrow

    10

    Sugammadex Octasodium

    Netherlands
    DCAT Week
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Anastrozole

    CEP/COS

    BIO-Europe Spring
    Not Confirmed
    arrow

    02

    Aripiprazole, Micronised

    CEP/COS

    BIO-Europe Spring
    Not Confirmed
    arrow

    03

    Bicalutamide, Micronised

    CEP/COS

    BIO-Europe Spring
    Not Confirmed
    arrow

    04

    Everolimus, BHT 2.0%

    CEP/COS

    BIO-Europe Spring
    Not Confirmed
    arrow

    05

    Exemestane, Micronised

    CEP/COS

    BIO-Europe Spring
    Not Confirmed
    arrow

    06

    Fingolimod hydrochloride

    CEP/COS

    BIO-Europe Spring
    Not Confirmed
    arrow

    07

    Flumazenil

    CEP/COS

    BIO-Europe Spring
    Not Confirmed
    arrow

    08

    Gefitinib, Micronised

    CEP/COS

    BIO-Europe Spring
    Not Confirmed
    arrow

    09

    Letrozole, Micronised

    CEP/COS

    BIO-Europe Spring
    Not Confirmed
    arrow

    10

    Pemetrexed disodium 2.5-hydrate

    CEP/COS

    Battery Seminar
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    NDC API

    read-more
    read-more

    01

    GLATIRAMER ACETATE

    Netherlands
    BIO-Europe Spring
    Not Confirmed
    arrow

    GLATIRAMER ACETATE

    Netherlands
    arrow
    BIO-Europe Spring
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Synthon Pharmaceuticals

    NDC Package Code : 24795-0063

    Start Marketing Date : 2014-08-08

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Drugs in Development

    read-more
    read-more
    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zydus and Synthon Entered into Exclusive Licensing and Supply Agreement for Ozanimod

    Details:

    Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product (generic version of Zeposia), and thereafter, for the manufacture and supply of the product.


    Lead Product(s): Ozanimod

    Therapeutic Area: Neurology Brand Name: Zeposia

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Zydus Lifesciences

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Licensing Agreement September 04, 2025

    blank

    01

    Synthon Pharmaceuticals

    Netherlands
    arrow
    BIO-Europe Spring
    Not Confirmed

    Synthon Pharmaceuticals

    Netherlands
    arrow
    BIO-Europe Spring
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Ozanimod

    Therapeutic Area : Neurology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Zydus Lifesciences

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    Zydus and Synthon Entered into Exclusive Licensing and Supply Agreement for Ozanimod

    Details : Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product (generic version of Zeposia), and thereafter, for the manufacture and supply of the product.

    Product Name : Zeposia

    Product Type : Miscellaneous

    Upfront Cash : Undisclosed

    September 04, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zydus Lifesciences in Pact with Synthon for Specialty Oncology Product in US

    Details:

    Zydus to handle NDA submission and commercialisation in the US and Synthon to lead development and manufacturing for oncology product.


    Lead Product(s): Undisclosed

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Undisclosed

    Recipient: Zydus Lifesciences

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement February 12, 2025

    blank

    02

    Synthon Pharmaceuticals

    Netherlands
    arrow
    BIO-Europe Spring
    Not Confirmed

    Synthon Pharmaceuticals

    Netherlands
    arrow
    BIO-Europe Spring
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Oncology

    Highest Development Status : Undisclosed

    Recipient : Zydus Lifesciences

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Zydus Lifesciences in Pact with Synthon for Specialty Oncology Product in US

    Details : Zydus to handle NDA submission and commercialisation in the US and Synthon to lead development and manufacturing for oncology product.

    Product Name : Undisclosed

    Product Type : Undisclosed

    Upfront Cash : Undisclosed

    February 12, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Efficacy and Safety of GTR in Comparison to Copaxone®

    Details:

    Glatiramer Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Multiple Sclerosis.


    Lead Product(s): Glatiramer Acetate

    Therapeutic Area: Neurology Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable December 09, 2011

    blank

    03

    Synthon Pharmaceuticals

    Netherlands
    arrow
    BIO-Europe Spring
    Not Confirmed

    Synthon Pharmaceuticals

    Netherlands
    arrow
    BIO-Europe Spring
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Glatiramer Acetate

    Therapeutic Area : Neurology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Efficacy and Safety of GTR in Comparison to Copaxone®

    Details : Glatiramer Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Multiple Sclerosis.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    December 09, 2011

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Synthon Pharmaceuticals and get a quotation

    Synthon Pharmaceuticals is a supplier offers 31 products (APIs, Excipients or Intermediates).

    Find a price of Flumazenil bulk with CEP, JDMF offered by Synthon Pharmaceuticals

    Find a price of Gefitinib bulk with CEP, JDMF offered by Synthon Pharmaceuticals

    Find a price of Sugammadex Sodium bulk with DMF, JDMF offered by Synthon Pharmaceuticals

    Find a price of Anagrelide Hydrochloride bulk with JDMF offered by Synthon Pharmaceuticals

    Find a price of Anastrozole bulk with CEP offered by Synthon Pharmaceuticals

    Find a price of Aripiprazole bulk with CEP offered by Synthon Pharmaceuticals

    Find a price of Axitinib bulk with DMF offered by Synthon Pharmaceuticals

    Find a price of Bicalutamide bulk with CEP offered by Synthon Pharmaceuticals

    Find a price of Enzalutamide bulk with DMF offered by Synthon Pharmaceuticals

    Find a price of Everolimus bulk with CEP offered by Synthon Pharmaceuticals

    Find a price of Exemestane bulk with CEP offered by Synthon Pharmaceuticals

    Find a price of Fingolimod Hydrochloride bulk with CEP offered by Synthon Pharmaceuticals

    Find a price of Ixazomib Citrate bulk with DMF offered by Synthon Pharmaceuticals

    Find a price of Lenalidomide bulk with DMF offered by Synthon Pharmaceuticals

    Find a price of Letrozole bulk with CEP offered by Synthon Pharmaceuticals

    Find a price of Mirabegron bulk with DMF offered by Synthon Pharmaceuticals

    Find a price of Ozanimod bulk with DMF offered by Synthon Pharmaceuticals

    Find a price of Palbociclib bulk with DMF offered by Synthon Pharmaceuticals

    Find a price of Pemetrexed Disodium bulk with CEP offered by Synthon Pharmaceuticals

    Find a price of Pomalidomide bulk with DMF offered by Synthon Pharmaceuticals

    Find a price of Pramipexole Dihydrochloride bulk with CEP offered by Synthon Pharmaceuticals

    Find a price of Siponimod bulk with DMF offered by Synthon Pharmaceuticals

    Find a price of Tamsulosin bulk with CEP offered by Synthon Pharmaceuticals

    Find a price of Tivozanib bulk with DMF offered by Synthon Pharmaceuticals

    Find a price of Valsartan bulk with DMF offered by Synthon Pharmaceuticals

    Find a price of Vismodegib bulk with DMF offered by Synthon Pharmaceuticals

    Find a price of Risperidone bulk offered by Synthon Pharmaceuticals

    Find a price of Zolpidem Tartrate bulk offered by Synthon Pharmaceuticals

    Find a price of Bortezomib bulk offered by Synthon Pharmaceuticals

    Find a price of Glatiramer Acetate bulk offered by Synthon Pharmaceuticals

    Find a price of Tamsulosin bulk offered by Synthon Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search